Archives
-
3X FLAG Peptide Workflow for Viral Protein Studies
2026-09-10
The 3X (DYKDDDDK) Peptide supports sensitive FLAG fusion-protein detection, competitive elution, and assay development when conventional single-epitope workflows are too weak. This guide connects practical tagging and purification decisions with the SARS-CoV-2 Nsp1–mRNA export study while clearly separating established evidence from recommended follow-up experiments.
-
WM-8014: From KAT6A Inhibition to Senescence
2026-09-09
WM-8014 is a reversible KAT6A inhibitor that connects acetyl-CoA-site competition with cell-cycle arrest and senescence. This article adds a time-aware assay framework inspired by RESTRICT-seq, helping researchers distinguish target engagement from nonspecific toxicity in cancer biology research.
-
2-Deoxy-D-glucose for Immunometabolic Assays
2026-09-09
Discover how 2-Deoxy-D-glucose and 2-DG can be integrated into whole-blood, cancer, and antiviral experiments without confusing metabolic inhibition with nonspecific toxicity. This guide translates standardized immunometabolism methods into practical assay decisions, controls, and interpretation strategies.
-
Tacrolimus (FK506): Reliable Cell Assay Design
2026-09-08
This scenario-driven guide explains how Tacrolimus (FK506), SKU B2143, can improve interpretation of T-cell activation, cytokine, proliferation, and cytotoxicity assays. It covers mechanism, solvent compatibility, concentration selection, metabolic-stress confounders, and practical vendor-selection criteria.
-
Prednisone for Reliable Cell Assays
2026-09-08
This scenario-driven guide explains how Prednisone, SKU B2148, can support interpretable lymphocyte viability, proliferation, cell-cycle, and apoptosis assays. It covers solvent control, dose–time design, matrix-aware interpretation, and practical criteria for selecting a reliable research-grade corticosteroid workflow.
-
Fast-Dissociating Antibodies for Single-Molecule Imaging
2026-09-07
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific antibodies with unusually rapid dissociation directly from hybridoma cultures. Their Fab probes support multiplexed super-resolution imaging and reveal rapid espin turnover within long-lived F-actin cores of inner-ear stereocilia, showing that fast off-rates can be experimentally useful rather than merely a liability.
-
Anagliptin Vasorelaxation: Kv Channels and SERCA
2026-09-07
A 2025 Acta Diabetologica study shows that Anagliptin relaxes phenylephrine-contracted rabbit aortic rings through pharmacologically supported involvement of voltage-dependent K+ channels and the SERCA pump. The response was independent of the endothelium and canonical cAMP/PKA or cGMP/PKG signaling, providing a focused framework for studying vascular effects beyond the drug’s established DPP-4 inhibition mechanism.
-
PNU 74654: Wnt Signaling Pathway Inhibitor Workflows
2026-09-05
Build reproducible Wnt/β-catenin pathway experiments with PNU 74654, from DMSO stock preparation to reporter, differentiation, and proliferation assays. The workflow emphasizes pathway-direction controls, dose-response design, and careful interpretation when translating findings from muscle progenitors to cancer or stem cell models.
-
CAY10499: Mapping Lipid Flux in Macrophages
2026-09-04
CAY10499, an inhibitor of human hormone sensitive lipase, enables mechanistic separation of lipase activity from ACLY-driven macrophage reprogramming. This article presents an assay strategy for connecting lipid hydrolysis, endocannabinoid turnover, and tumor-associated macrophage biology without overstating translational evidence.
-
Phosbind Acrylamide for TOR Phosphorylation Assays
2026-09-04
Phosbind Acrylamide enables antibody-free visualization of phosphorylation-dependent mobility shifts in proteins linked to TOR signaling. This workflow translates Neurospora nutrient-sensing findings into practical gel-based comparisons while preserving orthogonal controls for localization, complex formation, and phosphatase sensitivity.
-
A 83-01 ALK Inhibitor: Workflow & Applications
2026-09-03
A 83-01 is a selective ALK-5 inhibitor for separating TGF-β-driven transcription, EMT phenotypes, and growth responses from pathway-independent effects. This practical guide connects dose design, organoid and hepatocyte assays, the LPS/TLR4/YAP1 stemness model, and troubleshooting strategies for more interpretable experiments.
-
Poly (I:C): From dsRNA Signal to Translation
2026-09-03
Poly (I:C) is more than a broad immune stimulant: it is a controllable dsRNA signal for interrogating receptor context, interferon biology, mitochondrial ROS, and cell maturation. This thought-leadership article connects plant dsRNA immunity with mammalian translational workflows while outlining practical strategies for using Poly(I:C) with greater mechanistic precision.
-
GSK-923295 and the Logic of Mitotic Precision
2026-09-02
GSK-923295 offers a mechanistically defined way to interrogate CENP-E-dependent chromosome alignment, mitotic arrest, and tumor-cell response. This thought-leadership analysis connects pharmacologic motor inhibition with emerging evidence that CTCF preserves centromere architecture, providing a translational framework for cancer research beyond conventional product-page descriptions.
-
MAPK10-KRT16 Signaling in NSCLC Metastasis
2026-09-02
The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its combination of mechanistic, cellular, animal, and clinical analyses positions MAPK10 expression and KRT16 turnover as testable biomarkers and research targets, while also highlighting important limits on translating kinase perturbation findings into therapy.
-
Hearing Loss, LC–Norepinephrine, and Neurogenesis
2026-09-01
Liu and colleagues identify a causal circuit linking cochlear outer-hair-cell loss to reduced locus coeruleus norepinephrine signaling, impaired adult hippocampal neurogenesis, and cognitive decline in mice. Their rescue experiments show that stimulating PnC VGluT2-to-LC norepinephrine afferents can restore both neurogenic and behavioral outcomes, providing a mechanistic framework for studying hearing-related cognitive vulnerability.